Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

Abstract Background Lung immune prognostic index (LIPI) is a prognostic marker of extensive-stage small cell lung cancer (ES-SCLC) patients received immunotherapy or chemotherapy. However, its ability in limited-stage SCLC (LS-SCLC) should be evaluated extensively. Methods We retrospectively enrolle...

Full description

Bibliographic Details
Main Authors: Bochen Sun, Qing Hou, Yu Liang, Shuqin Xue, Ningning Yao, Lijuan Wei, Xin Cao, Hongwei Li, Hongwei Si, Jianzhong Cao
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Cancer
Subjects:
Lung immune prognostic index (LIPI)
Limited-stage small-cell lung cancer (LS-SCLC)
Prognostic biomarker
Immunity
Inflammation
Online Access:https://doi.org/10.1186/s12885-022-10351-7

Internet

https://doi.org/10.1186/s12885-022-10351-7

Similar Items